Biopol Chemicals Limited (BIOPOL)

Biopol Chemicals Limited has submitted its compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half-year ended September 30, 2026. The certificate from Cameo Corporate Services Limited confirms that physical shares received for dematerialisation were processed, cancelled, and substituted in depositories within prescribed time limits. This is a standard quarterly administrative filing confirming compliance with depository rules.

• Compliance certificate filed under Regulation 74(5) of SEBI Regulations, 2018
• Covers the quarter and half-year ended September 30, 2026
• Issued by Registrar and Share Transfer Agent Cameo Corporate Services Limited on October 07, 2026

Biopol Chemicals Limited announced the closure of its trading window effective Thursday, October 1, 2026. The restriction applies to Designated Persons, Promoters, Promoter Groups, and immediate relatives under SEBI Insider Trading Regulations. The window remains closed until 48 hours following the declaration of unaudited financial results for the half year ending September 30, 2026. The date of the board meeting to approve these results will be intimated separately.

• Trading window closes with effect from Thursday, October 1, 2026
• Closure period extends until 48 hours after disclosure of H1 financial results
• Results pertain to the half year ended September 30, 2026
• PANs of all Designated Persons to be frozen during the closure window

Biopol Chemicals Limited announced the voting results of its 3rd Annual General Meeting held on September 22, 2026. All four resolutions presented to shareholders were approved unanimously (100% of votes cast in favour). Key resolutions passed included the adoption of FY2026 financial statements, reappointment of director Mr. Vedant Sarkar, regularisation of Mr. Sukhomoy Das as Independent Director for 5 years, and approval of material related-party transactions.

• All 4 resolutions passed with 100.00% valid votes cast in favour
• A total of 73,59,400 equity shares were polled across 17 shareholders via remote e-voting
• Material Related Party Transactions approved with 2,48,900 public non-institutional votes; promoter group abstained as interested parties
• Regularisation of Mr. Sukhomoy Das as Independent Director for a 5-year consecutive term approved as a Special Resolution

Biopol Chemicals Limited announced that shareholders approved the regularisation of Mr. Sukhomoy Das as an Independent Director at its Annual General Meeting on September 22, 2026. Mr. Das was initially appointed as an Additional Director by the Board on June 11, 2026. His 5-year tenure will run from June 11, 2026 to June 10, 2031, not liable to retire by rotation. The AGM proceedings were brief, lasting 13 minutes from 02:00 PM to 02:13 PM.

• Shareholder approval regularises Mr. Sukhomoy Das as Independent Director effective September 22, 2026
• Term is fixed for 5 consecutive years from June 11, 2026 to June 10, 2031
• Mr. Das brings over 30 years of experience in clinical leadership, public policy, and corporate governance
• AGM commenced at 02:00 PM and concluded at 02:13 PM on September 22, 2026

Biopol Chemicals Limited conducted its 3rd Annual General Meeting on September 22, 2026, transacting four core resolutions. Shareholders considered the FY26 financial statements and approved the re-appointment of Whole-time Director Mr. Vedant Sarkar (holding 1,80,000 shares), who retires by rotation. Additionally, the AGM approved the regularisation of Mr. Sukhomoy Das as Independent Director for a 5-year term alongside an ordinary resolution approving material related-party transactions. The meeting took place via video conferencing and lasted 13 minutes, from 02:00 PM to 02:13 PM IST.

• 3rd Annual General Meeting conducted on September 22, 2026, from 02:00 PM to 02:13 PM IST
• Approved re-appointment of Whole-time Director Mr. Vedant Sarkar, who holds 1,80,000 shares in the company
• Approved regularisation of Mr. Sukhomoy Das as Non-Executive Independent Director for a term of 5 consecutive years
• Material Related Party Transaction(s) resolution tabled and transacted as an Ordinary Resolution

Biopol Chemicals Limited informed the exchange regarding its participation in the 53rd Dye+Chem Bangladesh 2026 INT'L Expo in Dhaka, Bangladesh. The industry trade event was held from September 2026 to September 5, 2026. The filing was submitted pursuant to Regulation 30 of SEBI LODR Regulations. No specific commercial contracts, order wins, or financial commitments were disclosed in the filing.

• Participated in the 53rd Dye+Chem Bangladesh 2026 INT'L Expo held at Dhaka, Bangladesh
• Event duration concluded on September 5, 2026
• Filing submitted under Regulation 30 read with Schedule III of SEBI LODR Regulations
• No commercial orders or financial figures disclosed in the announcement

Biopol Chemicals Limited submitted a formal response on August 31, 2026, to a surveillance inquiry from the National Stock Exchange dated August 28, 2026. The company confirmed that it has not withheld any material information or price-sensitive events required under Regulation 30 of SEBI LODR Regulations. Management clarified that the recent price movement in its scrip is purely market-driven by trading sentiment and demand-supply dynamics.

• Response submitted on August 31, 2026, addressing NSE inquiry NSE/CM/Surveillance/17439 dated August 28, 2026
• Company confirmed strict adherence to Regulation 30 of SEBI LODR Regulations
• Confirmed zero undisclosed material events or developments affecting scrip price or volume
• Management attributed recent share price movement entirely to market-driven trading dynamics

Biopol Chemicals Limited has issued an intimation under Regulation 36(1)(b) of SEBI LODR regarding the dispatch of letters containing the web-link for its FY 2025-26 Annual Report to shareholders whose email addresses are unregistered. The company's 3rd Annual General Meeting (AGM) is scheduled for September 22, 2026, at 02:00 PM IST via video conferencing. The cut-off date for e-voting entitlement is September 18, 2026, with remote e-voting active from September 19 to September 21, 2026.

• 3rd Annual General Meeting scheduled for September 22, 2026, at 02:00 PM IST via Video Conferencing
• Cut-off date for remote e-voting eligibility set for September 18, 2026
• Remote e-voting window opens September 19, 2026 (9:00 AM) and closes September 21, 2026 (5:00 PM)
• Dispatched web-link communication for the FY26 Annual Report to unregistered email shareholders

Biopol Chemicals Limited has issued the notice for its 3rd Annual General Meeting scheduled for September 22, 2026, via video conferencing. Key agenda items include adopting FY26 audited financial statements and appointing Mr. Sukhomoy Das as an Independent Director for a 5-year term. Notably, the company seeks shareholder approval for a material related party transaction to accept interest-free, unsecured loans of up to Rs 150 crore from promoters (max Rs 50 crore per individual lender) during FY27 to fund working capital and capex, against FY26 revenue of Rs 81.14 crore.

• 3rd Annual General Meeting scheduled for Tuesday, September 22, 2026 at 2:00 PM IST via VC/OAVM
• Seeking approval for interest-free unsecured loans from promoters up to an aggregate cap of Rs 150 crore in FY 2026-27 (limit of Rs 50 crore per lender)
• The Rs 50 crore individual facility represents ~61.62% of the company's FY 2025-26 annual turnover of Rs 8,114.33 lakhs
• Regularization of Independent Director Sukhomoy Das for a 5-year term from June 11, 2026 to June 10, 2031, with sitting fees capped at Rs 1.50 lakh per annum

Biopol Chemicals Limited announced the outcomes of its Board of Directors meeting held on August 25, 2026. The Board approved the convening of the 3rd Annual General Meeting (AGM) on September 22, 2026, via video conferencing. Key approvals include the appointment of M/s. M.K Chokshi & Associates as Secretarial Auditor and M/s. Nikhar Agarwal & Co. as Internal Auditor for FY 2026-27, alongside regularizing Mr. Sukhomoy Das as an Independent Director for a 5-year term. The Board also approved material related-party transactions to be placed before shareholders.

• 3rd Annual General Meeting scheduled for September 22, 2026 at 02:00 PM IST via VC/OAVM
• Cut-off date for dispatch of AGM notice and FY 2025-26 Annual Report set as August 21, 2026
• Appointed M/s. M.K Chokshi & Associates as Secretarial Auditor for FY 2026-27
• Appointed M/s. Nikhar Agarwal & Co. as Internal Auditor for FY 2026-27
• Approved regularization of Mr. Sukhomoy Das as Independent Director for a 5-year tenure

Biopol Chemicals Limited has informed the exchange that Mrs. Vandan Vij Sarkar (DIN: 02198810) has resigned as Non-Executive Non-Independent Director of the company. The resignation is effective immediately from August 24, 2026. In her resignation letter, she cited other professional engagements and commitments as the reason, confirming no other material reasons exist.

• Resignation of Mrs. Vandan Vij Sarkar (DIN: 02198810) as Non-Executive Non-Independent Director
• Cessation effective from Monday, August 24, 2026
• Reason stated is other professional engagements and commitments with no other material reasons

Biopol Chemicals Limited announced the resignation of Mrs. Vandan Vij Sarkar (DIN: 02198810) from her position as Non-Executive Non-Independent Director, effective August 24, 2026. The resignation is attributed to other professional engagements and commitments, with no other material reasons cited. The company will note the resignation at its upcoming Board meeting and complete necessary filings with the Registrar of Companies.

• Resignation of Non-Executive Non-Independent Director Mrs. Vandan Vij Sarkar effective August 24, 2026
• Reason cited as other professional engagements and commitments with no material disputes reported
• Intimation submitted under Regulation 30 of SEBI Listing Regulations on August 24, 2026